Item 8.01 Other Events.

On October 7, 2009, Hana Biosciences, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with certain accredited investors pursuant to which the Company agreed to sell in a private placement (the "Offering") an aggregate of 54,593,864 units (the "Units"), each Unit consisting of shares of the Company's common stock, par value $0.001 (the "Common Stock"), and warrants to purchase additional shares of Common Stock, the terms of which were disclosed by the Company in a Current Report on Form 8-K filed with the Securities and Exchange Commission on October 8, 2009. On October 8, 2009, the Company completed the transactions contemplated by the Purchase Agreement.